Physician profile
Bethany Carol Risen
NPI 1790564912
$420.48
in general payments reported to CMS, 2019-2025
10 companies · $375 in 2025
The $375 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $45.30 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $420.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $77.10 | 2025 | Farxiga |
| Alnylam Pharmaceuticals INC. | $66.18 | 2025 | Onpattro |
| Bridgebio Pharma, INC. | $53.79 | 2025 | Attruby |
| Merck Sharp & Dohme LLC | $51.44 | 2025 | Verquvo, Capvaxive |
| Pfizer INC. | $45.92 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.32 | 2025 | |
| Baxter Healthcare | $31.30 | 2024 | Preveleak |
| Scpharmaceuticals INC. | $21.19 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.24 | 2025 | Jardiance |
| Biomerieux INC | $14.00 | 2024 | Vidas Nephrocheck |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethany Risen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.